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De novo chromatin assembly maintains histone density on the
daughter strands in the wake of the replication fork. The hetero-
trimer chromatin assembly factor 1 (CAF-1) couples DNA replication
to histone deposition in vitro, but is not essential for yeast cell
proliferation. Depletion of CAF-1 in human cell lines demonstrated
that CAF-1 was required for efficient progression through S-phase.
Cells lacking CAF-1 accumulated in early and mid S-phase and
replicated DNA slowly. The checkpoint kinase Chk1, but not Chk2,
was phosphorylated in response to CAF-1 depletion, consistent
with a DNA replication defect. CAF-1-depleted cell extracts com-
pletely lacked DNA replication-coupled chromatin assembly activ-
ity, suggesting that CAF-1 is required for efficient S-phase progres-
sion in human cells. These results indicate that, in contrast to yeast,
human CAF-1 is necessary for coupling chromatin assembly with
DNA replication.
In eukaryotic cells, DNA is packaged into chromatin that is thein vivo substrate for the DNA replication machinery. Parental
nucleosomes are transiently removed from DNA and quickly
assemble behind the DNA replication fork (1–4). New nucleo-
somes are also deposited de novo at the replication fork in a
reaction catalyzed by chromatin assembly factor 1 (CAF-1) (5,
6). CAF-1 consists of three polypeptides with apparent masses of
150, 60, and 48 kDa that bind histones H3 and H4 and deposits
the histone tetramer preferentially onto replicating DNA (7).
H2AB dimers are then loaded in a second step that is not
necessarily coupled to DNA replication (8). The biochemical
activity of CAF-1 in nucleosome deposition depends on its
interaction with the DNA polymerase sliding clamp, proliferat-
ing cell nuclear antigen (PCNA) (9–11) and consistent with its
activity in vitro, CAF-1 is found in replication foci during S-phase
and is also associated with PCNA foci after DNA damage (9, 12,
13). CAF-1 also deposits nucleosomes during DNA repair on
damaged DNA templates in vitro. This intimate connection
between CAF-1 and the replication machinery suggests that
tightly coupling DNA replication and chromatin assembly may
be required for normal S-phase progression.
Given that de novo nucleosome assembly is likely an essential
process, it is surprising that yeast lacking CAF-1 are viable with
no apparent cell proliferation phenotype (14, 15). This obser-
vation suggested that other chromatin assembly pathways com-
pensate for the loss of yeast CAF-1. Indeed, other factors, such
as Asf1 and the histone regulating (Hir) proteins, are known
histone binding proteins (16, 17), and deletion of these genes in
combination with CAF-1 leads to severe gene silencing and cell
proliferation defects (18–20). The human HIRA protein, an
ortholog of yeast Hir1, Hir2, and Hir3 proteins, has recently been
shown to participate in replication-independent nucleosome
assembly, and a similar pathway may suffice in yeast deficient in
both the CAF-1 and Asf1 pathways for chromatin assembly (21).
Disruption of CAF-1 in yeast results in gene silencing defects
at telomeres and at the silent mating type loci, and these
phenotypes are enhanced when Asf1 is deleted (14, 15, 18).
Similarly, overexpression of a truncated version of CAF-1 leads
to expression of a silenced transgene in human cells and devel-
opmental defects in Xenopus embryos (22, 23). Thus, the loss or
inhibition of CAF-1 can affect the assembly of chromatin
structures that repress transcription in both yeast and humans.
Because CAF-1 is tightly linked to replication foci in vivo and
because human chromatin is significantly more complex than
yeast chromatin, we speculated that CAF-1 might play an
important role in human cell proliferation. The function of
human CAF-1 was investigated by small interfering RNA
(siRNA)-mediated knockdown of the complex. In contrast to
yeast, human CAF-1 was required for efficient progression
through S-phase and the loss of CAF-1 activated a specific
checkpoint. Furthermore, loss of CAF-1 completely eliminated
any replication-coupled chromatin assembly activity in cell ex-
tracts, indicating that this protein is the predominant chromatin
assembly machine at the replication fork. These results demon-
strate that CAF-1 is required for efficient replication fork
progression and that the S-phase checkpoint machinery moni-
tors chromatin assembly.
Materials and Methods
Cell Culture and Transfection. RKO and HeLa cells were main-
tained in standard media. Transfection of RKO and HeLa cells
was done by using Oligofectamine (Invitrogen) using a 200 or
100 nM oligo concentration, respectively. Two rounds of trans-
fection at 0 and 24 h were done for all experiments. siRNA oligos
were from Dharmacon and the targeting sequences of each were
control GL3 (directed against firefly luciferase): CUUACGCU-
GAGUACUUCGAdTdT; 150-1, AGGGGAAAGCCGAUGA-
CAUdTdT; and 150-2, CUGUCAUGUGGGUUCUGAC-
dTdT.
Flow Cytometric Analysis. For cell cycle flow cytometric analysis,
cells were collected by trypsinization, washed, fixed in cold
methanol, washed, and stained in 20 gml propidium iodide
(PI) plus 10 gml RNase. Cells were analyzed on a Coulter
Epics Elite instrument. For BrdUrdPI flow cytometric analysis,
cells were collected, fixed in methanol, and stained with FITC
conjugated anti-BrdUrd (Becton Dickinson) and propidium
iodide (for details, see Supporting Text, which is published as
supporting information on the PNAS web site, www.pnas.org).
Western Blots and Immunofluorescence. Total cell extracts were
separated on SDS10% PAGE gels transferred to nitrocellulose
and processed for Western analysis. CAF-1 p150 was detected
with the SS1 or SS48 monoclonal antibodies, CAF-1 p60 was
detected with the SS53 antibody, and PCNA was detected with
the PC10 antibody. Anti-Chk1, anti-Chk1 phospho-S317, anti-
Chk2 phospho-T68, anti-p53 phospho-S15 (Cell Signaling Tech-
nologies), anti-p53 (CM1, NovoCastra), and anti-p21CIP1
WAF1 (BD Transduction Laboratories) were also used. Details
of antibody dilutions can be found in Supporting Text.
For immunofluorescence analysis, cells were plated on cov-
Abbreviations: CAF-1, chromatin assembly factor 1; PCNA, proliferating cell nuclear anti-
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erslips 16 h before transfection. After transfection, cells were
fixed in 2% paraformaldehyde in PBS and processed for immu-
nofluorescence (see Supporting Text for detailed protocols). To
visualize chromatin bound PCNA, cells were preextracted with
Triton X-100 in CSK buffer (13). Primary antibodies used were
anti-CAF-1 p150 SS1, anti-PCNA PC10, anti-p53 phospho-S15,
anti-Chk1 phospho-S317, and Alexa Fluor 594-conjugated anti-
BrdUrd (Molecular Probes). Secondary antibodies were goat
Texas Red anti-rabbit or FITC anti-mouse (The Jackson Lab-
oratory). Cells were visualized on a Zeiss Axioplan or Axiophot
microscope using 40 or 63 oil-immersion objectives. Images
were processed by using OPENLAB v. 3.1.1 software and transferred
to PHOTOSHOP (version 6.0; Adobe Systems, Mountain View,
CA) for assembly.
In Vitro Chromatin Assembly Assays. HeLa cell extracts were
prepared from two plates of siRNA-transfected cells at 48 h, by
using an extraction protocol (24) in which cytoplasmic cell
extracts (designated the S100 fraction) and nuclei were prepared
by hypotonic lysis and mechanical disruption of cells through a
25G 1⁄2 needle. Nuclear extracts containing CAF-1 were pre-
pared by high salt extraction of nuclear pellets (see Supporting
Text). Chromatin assembly assays were performed as described
(9). In the one-step assay, 10, 20, and 30 g of nuclear extract was
used as a source of CAF-1. For the two-step assay, 20 fmol of in
vitro-replicated DNA purified by filtration through a spun col-
umn was assembled in the presence or absence of 40 fmol of
recombinant CAF-1 and 25 or 50 g of S100 extract as a source
of histone H3H4 and other unidentified factors necessary for
assembly. Exogenous topoisomerase I (1 unit per reaction,
Takara Shuzo, Kyoto), topoisomerase II (100 ng), and histone
H2AB dimers (280 ng), which were limiting in the reaction,
were also added. Recombinant CAF-1 and simian virus 40
(SV40) T antigen were from baculovirus infected Sf9 cells (9),
topoisomerase II was from calf thymus (25), and H2AB dimers
(26) were from human cells.
Results
CAF-1 Is Required for Normal S-Phase Progression. To examine the
function of CAF-1 in human cells, two siRNAs against the
mRNA encoding the p150 subunit of the complex were designed
(27, 28). Transfection of either of these oligos, but not a
nonspecific control oligo, resulted in dramatic knockdown of
CAF-1 in RKO cells. By transfecting twice at 24-h intervals,
significant knockdown was achieved in 95% of cells by 48 h
after transfection (Fig. 1A and data not shown). A concomitant
decrease in the p60 protein of the CAF-1 complex was also
detected by Western blot analysis. Because immunodepletion
experiments indicate that the two largest subunits of CAF-1 in
293 nuclear extracts exist almost entirely in a complex (data not
shown), the synchronous decrease of the p60 subunit probably
reflects increased turnover of the free subunit. Therefore,
knockdown of p150 significantly depletes the levels of CAF-1
activity in RKO cells. In contrast, the levels of PCNA, a
CAF-1-associated protein (9), were not affected (Fig. 1A).
The cell cycle distribution of cells lacking CAF-1 was com-
pared with cells treated with control siRNA. RKO cells lacking
CAF-1 accumulated with an increased S-phase DNA content by
48 h and further increased by 72 h (Fig. 1B). A population of cells
with sub-2C DNA content also became apparent at 72 h and may
represent an early apoptotic population. Similar accumulation of
cells in S-phase was seen with both HeLa and HCT116 cells (data
not shown). To further examine the nature of the defect in
S-phase progression, cells were pulsed for either 10 min or 24 h
with BrdUrd and immunostained for BrdUrd and CAF-1. Cells
exhibited reduced or no staining for BrdUrd after a 10-min pulse
and greatly reduced staining compared with cells that contained
CAF-1 after a 24-h label, indicating that DNA replication had
slowed but was not completely inhibited (Fig. 2A). Examining
BrdUrd incorporation in cells with S-phase DNA content by
using two-dimensional f low cytometric analysis confirmed this
result. As before, knockdown of p150 resulted in an increase in
the amount of cells in S-phase by 48 h, but the cells incorporated
BrdUrd poorly as evidenced by the spread of the arc of S-phase
cells in CAF-1-depleted cells compared with control cells,
indicating a defect in DNA replication (Fig. 2B). The defect in
BrdUrd incorporation was more severe at 72 h. Pretreatment of
RKO cells with 2 mM hydroxyurea (HU) for 1 h blocked all
BrdUrd incorporation, demonstrating that the nonzero amount
of incorporation in CAF-1-depleted cells was not caused by
background staining (data not shown). We conclude that loss of
CAF-1 resulted in slow DNA replication and accumulation of
cells in S-phase.
CAF-1-Negative Cells Accumulate in Early and Mid S-Phase. CAF-1
localizes to DNA replication foci throughout S-phase, and loss
of CAF-1 might affect replication by interfering with the re-
cruitment of replication factors (9). CAF-1 also functions in the
replication and maturation of heterochromatin because it local-
izes at sites of heterochromatin replication in late S-phase (12)
and binds to and recruits the heterochromatic HP-1 proteins to
DNA in vitro (29), and loss of CAF-1 leads to silencing defects
in yeast and human cells (14, 15, 22). Thus, loss of CAF-1 might
disproportionately affect replication of heterochromatin, lead-
ing to an altered distribution of replication foci in cells. To
examine this possibility, cells were stained with PCNA after
RNA interference (RNAi) treatment and the distribution of
replication foci was determined. The stage of S-phase can be
distinguished by characteristic patterns of PCNA staining that
cells exhibit in early, mid, and late S-phase (30–32) (Fig. 3A).
Late S-phase patterns (4 and 5) have less numerous, large foci
throughout the nucleoplasm and at the nuclear periphery. Cells
Fig. 1. RNAi of CAF-1 induces the accumulation of cells in S-phase (A)
Western blot analysis of total cell extract of cells treated with control oligo or
with two different oligos targeting CAF-1 p150. Equal amounts of cell extract
were loaded and probed with antibodies against CAF-1 p150, CAF-1 p60, and
PCNA. Note that the bulk of p60 is depleted in p150 knockdown cells. (B) Cell
cycle analysis of control and CAF-1-depleted cells at 48 and 72 h after trans-
fection. DNA content was measured by flow cytometry.
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were stained for chromatin-bound PCNA, and replication foci in
control or CAF-1 RNAi-treated cells were examined. A sub-
stantial decrease in the number of cells displaying late S-phase
patterns in CAF-1-deficient cells (Fig. 3 B and C) and a
corresponding increase in both early and mid S-phase patterns
were observed. No abnormal replication patterns were noted,
suggesting that replication factories were assembled correctly
and that the replication defect occurred downstream of PCNA
recruitment. The lower amount of late S-phase cells may be due
to difficulty replicating heterochromatin, but could also be due
to a more global defect in S-phase progression.
Loss of CAF-1 Activates Checkpoints. Reduced rates of DNA rep-
lication and slow or stalled replication forks can cause activation
of an intra-S-phase checkpoint (33). The checkpoint kinase ATR
activates the downstream kinase Chk1 by phosphorylation on
S317 and S345 preferentially in response to replication fork
stress or the presence of bulky adducts in DNA (34). In contrast,
ATM is activated preferentially in response to double-strand
DNA breaks in human cells and activates the Chk2 kinase by
phosphorylation of T68 (35–37). Both ATM and ATR phos-
phorylate p53 on S15, leading to increased transcriptional trans-
activation potential of this protein (38). To test whether loss of
CAF-1-activated checkpoint pathways in RKO cells, phospho-
specific antibodies against Chk1, Chk2, and p53 were used.
Phosphorylation of S317 of Chk1 was detected in cells lacking
CAF-1, but phosphorylation of Chk2 was not induced (Fig. 4A).
p53 levels were induced by 48 h, and the induced protein was
phosphorylated on S15 (Fig. 4A). Accumulation of the p53
transcriptional target, p21 was also detected, indicating that p53
was active in these cells (Fig. 4A). The activation of Chk1 and not
Chk2 implied that the ATR branch of the DNA damage response
pathway had been activated, consistent with CAF-1 deficiency
causing a defect in ongoing DNA replication.
The slow replication seen in CAF-1 knockdown cells might be
caused by a primary defect in DNA replication or by the
activation of the checkpoint machinery. To analyze this, the
onset of the DNA replication defect was compared with check-
point activation by monitoring p53 and Chk1 phosphorylation
and BrdUrd incorporation by immunofluorescence analysis be-
tween 24 and 60 h after transfection. A decrease BrdUrd
incorporation was detected by 36 h, and DNA replication
appeared largely inhibited by 60 h after transfection, although
very dim replication foci were still detectable (Fig. 4 B and C).
However, significant phosphorylation of p53 was seen only by
48 h and accumulated in more cells by 60 h (Fig. 4C and Fig. 6,
which is published as supporting information on the PNAS web
site). p53 phosphorylation increased 50-fold by 60 h as com-
pared with control cells (Fig. 4C), whereas Chk1 phosphoryla-
tion increased 4-fold relative to control, probably because there
was some activation even in control cells (Fig. 4A, lane C, 48 h).
These data indicate that activation of p53 and Chk1 occur
concomitant with or slightly after the onset of the replication
defect.
CAF-1 Is Necessary and Sufficient for Replication-Coupled Chromatin
Assembly. CAF-1 purified from human cell nuclei assembled
chromatin in the presence of an S100 extract that supported
Fig. 2. Loss of CAF-1 leads to slowS-phaseprogression. (A) CAF-1 knockdown
cells pulsed for 10 min (48 h after transfection) or 24 h (36–60 h after
transfection) with 40 M BrdUrd and stained with antibodies specific for
BrdUrd and p150. Control cells display high levels of BrdUrd incorporation,
whereas CAF-1-depleted cells do not incorporate BrdUrd efficiently (arrows).
(B) Two-dimensional flow cytometry analysis monitoring BrdUrd incorpora-
tion and DNA content. Cells were pulsed with BrdUrd for 10 min, fixed, and
stained with FITC-conjugated anti-BrdUrd antibody and propidium iodide to
stain theDNA. BrdUrd intensity is plotted on a log scale on the y axis, andDNA
content is plotted on the x axis. G1, G2, and S-phase populations are gated in
each sample, and the numbers in the upper right indicate the percentage of
BrdUrd-positive cells in each sample.
Fig. 3. CAF-1-depleted cells assemble normal replication foci and accumu-
late in early tomid S-phase. (A) Cells were stained for chromatin-bound PCNA
and scored for replication patterns. Examples of early, mid, and late S-phase
patterns are provided. (B) Late S-phase patterns are easily seen in control cells
but are found less frequently in cells treated with either CAF-1-targeted
siRNA. Arrows indicate examples of early,middle, and late replication sites (”,
early S-phase patterns;3, middle S-phase patterns;–, late S-phase patterns).
(C) Distribution of S-phase cells displaying early, mid, or late S-phase replica-
tion patterns 48 h after transfection. Three hundred S-phase cells were
counted per sample, and the results are the mean from two independent
experiments.








SV40 DNA replication (5, 7). Because CAF-1 is not essential in
yeast, it was possible that other factors present in the nuclear
extract could substitute for CAF-1 in the DNA replication-
coupled chromatin assembly reaction. Therefore, a nuclear
extract from cells transfected with the CAF-1 siRNA was tested
for chromatin assembly activity. Small-scale nuclear and S100
extracts were prepared from HeLa cells 48 h after they had been
transfected with control or p150 targeting siRNAs. CAF-1
partitioned exclusively to the nuclear extract, whereas PCNA was
found in both fractions (Fig. 5A). Extract from cells transfected
with control oligonucleotide was capable of supporting chroma-
tin assembly preferentially on replicating templates as measured
Fig. 4. Checkpoint activation in CAF-1-depleted cells. (A)Western analysis of
total cell lysate after CAF-1 RNAi to monitor checkpoint activation by using
phospho-specific antibodies to p53 S15, Chk1 S317, and Chk2 T68. Overall
Chk2 levels do not change (data not shown). Extract of cells treated with
hydroxyurea (20 mM) for 24 h, which leads to phosphorylation of all three
proteins, was included as a positive control. (B) Time course of checkpoint
activation and BrdUrd incorporation in control and CAF-1-depleted cells.
Three coverslips were seeded per well and transfected according to the
standard protocol. Cells were collected at 24, 36, 48, and 60 h after transfec-
tion, pulsed for 10 min with BrdUrd, and stained with phospho-specific
antibodies against S15 of p53, S317 of Chk1, or BrdUrd. Cells in the 24-h time
point had only been transfected once. Some loss in BrdUrd incorporation was
seen by 36 h in comparison to control, and BrdUrd incorporation drops
dramatically at 48 h after transfection. (C) Plot comparing checkpoint activa-
tion and BrdUrd incorporation in individual CAF-1 knockdown cells normal-
ized to control transfected cells. Three hundred cells were counted per time
point for eachantibody for control andCAF-1 targetingoligo1, and the results
shown are the mean for two experiments. All cells displaying checkpoint
activation above background and only brightly BrdUrd-labeled cells were
scored as positive. Significant checkpoint activation was not seen until 48 h
after transfection.
Fig. 5. Replication coupled chromatin assembly activity depends on CAF-1.
(A) Western blot analysis of CAF-1 in HeLa nuclear and S100 fractions after
RNAi. (B) One-step chromatin assembly assays tomonitor the ability of control
and CAF-1-depleted nuclear extracts to assemble replicating SV40 DNA into
nucleosomes. pSV011 DNA containing the SV40 origin was replicated in a
replication mix containing 32P-dATP to label replicated DNA and was assem-
bled into chromatin with nuclear extract or recombinant CAF-1. DNA pack-
aged into chromatinaccumulatednegative supercoils and runswithenhanced
mobility relative to unassembled DNA [compare lane 1 (low CAF-1) to lanes
2–4 (sufficient CAF-1)]. The bulk of unreplicated DNA visualized by ethidium
bromide staining (Lower) remained relaxed, indicating that the CAF-1 pref-
erentially loaded nucleosomes onto replicating DNA. When CAF-1 was de-
pleted by RNAi (lanes 5–7 and 9–11), assembly did not occur. Addition of
recombinant CAF-1 restored assembly activity in these extracts (lanes 8 and
12). Nuclear extract (10–30 g) was titrated into each set of reactions. (C)
Two-step chromatin assembly assays demonstrate that the S100 from CAF-1
knockdown cells contain all accessory factors (including histones H3 and H4)
required to assemble chromatin. SV40 DNA was replicated in a S100 replica-
tion extract, purified away from proteins by gel filtration and incubated with
S100 from control or p150-depleted extracts in the presence or absence of
CAF-1. Twenty-five and 50 g of extract were used in each reaction. Under
these conditions, assembly into chromatin required CAF-1 (compare lanes 3
and 4, CAF-1) and S100 (compare lanes 2 and 4). Unreplicated DNA seen
in theethidium stain (Lower)was not assembled into chromatin and remained
largely relaxed.
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by the increased supercoiling of the replicated template in the
presence of CAF-1, whereas extract from p150 knockdown cells
was unable to support chromatin assembly (Fig. 5B). This was
due explicitly to the defect in CAF-1 protein because the
addition of purified recombinant CAF-1 restored assembly
activity to normal levels. This demonstrated that CAF-1 is
essential for DNA-replication-coupled chromatin assembly in
human cell extracts.
Ongoing histone synthesis during S-phase is required for
efficient S-phase progression and ectopic expression of the Hir
proteins, which repress the expression of histone genes and
results in a replication defect similar to that seen with loss of
CAF-1 (17, 39, 40) Therefore, one explanation for accumulation
of cells in S-phase could be that loss of CAF-1 indirectly affects
levels of unincorporated and newly synthesized histones. A pool
of these histones is present in the cytoplasm of cells and the H3
and H4 present in this fraction is essential for the postreplicative
chromatin assembly that is mediated by CAF-1 (9, 41). To
determine whether histones H3 and H4 were limiting in CAF-
1-depleted extracts, a two-step chromatin assembly assay was
used in which SV40 DNA was first replicated and radiolabeled
in vitro in a standard DNA replication reaction, then the resulting
DNA–protein complexes were purified away from the other
protein components required for DNA replication by a rapid gel
filtration step. This ‘‘marked’’ DNA was subsequently assembled
into chromatin in a second reaction dependent on CAF-1 (9, 41).
CAF-1 was able to assemble chromatin on this replicated DNA
because PCNA remains topologically linked to the DNA after
replication and can recruit CAF-1. The subsequent chromatin
assembly reaction required components supplied by the S100
extract, including histones H3 and H4 (41). There was no defect
in the ability of the S100 extract prepared from cells lacking
CAF-1 to support the ability of recombinant CAF-1 to assemble
chromatin in this assay (Fig. 5C). Furthermore, the total levels
of histone H3 were unaffected in CAF-1 knockdown cells (data
not shown). These results suggest that depletion of CAF-1 is
unlikely to have effects on histone synthesis or stability.
Discussion
Chromatin assembly and DNA replication are tightly coupled in
eukaryotic cells. Nucleosomes are only transiently disrupted
ahead of the replication fork and are rapidly deposited and
positioned behind the replication fork (1, 3, 4, 42, 43). The
chromatin assembly protein CAF-1 has long been hypothesized
to couple chromatin assembly to DNA replication in eukaryotic
cells, but this hypothesis was thrown into question when loss of
CAF-1 led to only modest phenotypes in yeast (14, 15). In this
report, we show that CAF-1 is the dominant replication-coupled
chromatin assembly machine in human cells and that loss of
CAF-1 leads to defects in DNA replication and S-phase pro-
gression, suggesting that, in human cells, CAF-1 couples chro-
matin assembly to DNA replication and is essential for cell
proliferation.
Several studies that reported overexpression of dominant-
negative versions of CAF-1 have also concluded that CAF-1 is
essential for cell proliferation. Overexpression of human CAF-1
p150 in Xenopus inhibited proper embryo development by
interfering with cell division (23). Similarly, transient overex-
pression of versions of CAF-1 that were unable to bind PCNA
led to an S-phase arrest in human cells (44). This study also
showed that expression of dominant-negative CAF-1 induced an
intra-S-phase checkpoint and that dominant negative ATR could
abrogate the S-phase arrest only in cell lines also deficient for
ATM, consistent with a role for both kinases in mediating
dominant negative CAF-1 induced arrest. However, in both
studies, cryptic functions of the dominant-negative constructs
could have played a role in inducing the observed proliferation
defects. Our experiments, however, using a distinct RNAi meth-
odology to eliminate CAF-1 function are consistent with the
previous studies and demonstrate a fundamental role for CAF-1
in S-phase progression. This was unlikely to be caused by
depletion of cytoplasmic pools of H3 and H4 or other cellular
factors required for DNA replication and chromatin assembly in
vitro.
What is the role of CAF-1 in S-phase progression? Replication
forks are assembled normally, because normal S-phase staining
patterns of PCNA in CAF-1 depleted cells were seen and other
replication proteins such as RPA, RFC, and DNA polymerase-
were still recruited to the chromatin (data not shown). However,
cells deficient in CAF-1 accumulated in early and mid-S-phase,
demonstrating that progression through S-phase was inhibited.
This could be caused by either stalling of replication forks in
early S-phase, the activation of the intra-S-phase checkpoint in
response to chromatin defects, or a specific defect in hetero-
chromatin replication. Heterochromatin generally replicates late
in S-phase, and a partial explanation of the S-phase progression
defect might be that CAF-1 plays a particular and distinct role
in heterochromatin replication. Proteins such as HP1 that mark
heterochromatin have the potential to crosslink chromatin fibers
into a compact and potentially less accessible structure through
self-association (45, 46). Because CAF-1 binds the HP1 chromo-
shadow domain, it may play a role in destabilizing heterochro-
matic structures during replication, allowing the replication
machinery to progress efficiently through heterochromatin,
thereby explaining why the loss of CAF-1 could lead to an
accumulation of early and mid-S-phase cells.
CAF-1, however, localizes to replication foci throughout S-
phase and is intimately tied to all replication forks because of its
interaction with PCNA. This observation suggests that CAF-1
probably plays a more general role in DNA replication that could
include a role in handling nucleosomes both ahead of and behind
the replication fork. Analysis of replicating SV40 minichromo-
somes has shown that nucleosomes are transiently disrupted just
ahead of the replication fork and assemble quickly behind the
replication fork (2). H2A and H2B are exchanged during rep-
lication, but H3 and H4 tetramers remain associated with DNA
(1). Thus, an H3H4 chaperone associated with the replication
fork such as CAF-1 or Asf1 might be involved in the transient
destabilization of nucleosomes required for replication fork
passage and interfering with this function could interfere with
progression of the replication fork. Alternatively, loss of CAF-1
might affect replication more indirectly by altering DNA topol-
ogy. Nucleosomes contribute to the topological state of the
genome because they introduce negative supercoils into the
DNA. The overall superhelical density on a given piece of DNA
might be significantly reduced in the absence of CAF-1 mediated
chromatin assembly. Negative supercoils can contribute to local
DNA unwinding, and disruption of nucleosomes may be impor-
tant in replication fork progression. In support of a role for DNA
topology in mammalian replication, the protein DEK-1 has
recently been shown to reduce the superhelical density of
nucleosomal DNA without stripping the histones (47) and
incubation of SV40 chromosomes with DEK-1 significantly
reduced the efficiency of DNA replication in vitro (48).
Stalled replication forks are well known to activate the intra-
S-phase checkpoint and changes in DNA topology or the expo-
sure of excessive amounts of naked DNA may be novel lesions
monitored by the checkpoint machinery. We detected activation
of Chk1, but not Chk2, and activation of p53 and its transcrip-
tional target p21 in CAF-1 knockdown cells. Activated Chk1
promotes the degradation of Cdc25A, thus interfering with CDK
activity and leading to slow S-phase progression (49). Addition-
ally, up-regulation of p21 through p53 might play a role in the
replication arrest, either because p21 associates with PCNA in
response to DNA damage and inhibits DNA replication in vitro








or hinders the progression to later stages of S-phase through its
CDK inhibitory action (50–52).
Our data suggest that the onset of the replication defect
precedes or occurs simultaneously with checkpoint activation,
although low levels of checkpoint activity below the threshold of
detection could be present at earlier time points. Thus, check-
point activation may be caused by the presence of stalled
replication forks induced by the loss of CAF-1. However, CAF-1
might also have a more intimate connection with the checkpoint
machinery. In yeast, the Asf1 chromatin assembly protein inter-
acts with Rad53, a homolog of human Chk2 (53, 54). In response
to DNA damage, Asf1 is released from Rad53 and is free to bind
H3 and H4 and promote chromatin assembly. Overexpression of
Asf1 suppresses the hydroxyurea sensitivity of rad53–21mutants,
tying Asf1 to the checkpoint and replication functions of Rad53
(53). CAF-1 and Asf1 also function in the maintenance of
genomic integrity in yeast, because loss of these genes in
conjunction with checkpoint genes such as tel1, chk1, and dpb11
leads to an increase in gross chromosomal rearrangements and
in the mutation rate (55). In human cells, Chk1, which is thought
to monitor replication in a similar way to yeast Rad53, activates
Tlk kinases that, in turn, target Asf1 and potentially other
chromatin deposition factors in response to DNA damage (56).
Thus, CAF-1 and Asf1 may directly signal the state of chromatin
to the checkpoint machinery and loss of these proteins might
lead in to checkpoint activation (13, 15).
In mammalian cells, histone H3 comes in two major forms,
histone H3.1 and histone H3.3. The former is loaded onto
replicated DNA, whereas H3.3 replaces H3.1 in transcribed
regions of the genome (57). Interestingly, Saccharomyces cerevi-
siae only has the H3.3 version of histone H3, probably because
most of the genome is transcribed (58). Therefore, we suggest
that CAF-1 is not essential in yeast because the discrimination
between the two related forms of chromatin does not exist. In
human cells, however, CAF-1 would predominantly deposit and
maintain histone H3.1 type nucleosomes onto the replicating
DNA, and is therefore essential.
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